GFAP and Cognitive impairment: Various studies reported pathological astrogliosis, both in AD patients and in transgenic animals, characterized by an increase in the glial fibrillary acidic protein (GFAP) and a distinct cellular hypertrophy, which somehow correlates with the severity of cognitive impairment in AD patients [124].